(Q38700746)

5 September 2017

Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes (English)

1 reference

5 September 2017

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Eleonora Maretti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Valentina Iannuccelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Eliana Leo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Eleonora Truzzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Chiara Bongio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Monica Montanari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Elena Vismara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

9 June 2017

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

31 May 2020

copyright license

start time

9 June 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Recent approaches of lipid-based delivery system for lymphatic targeting via oral route

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Solid lipid nanoparticles for parenteral drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Zeta potential measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Magnetic nanoparticles for theragnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Non-covalent synthesis of metal oxide nanoparticle-heparin hybrid systems: a new approach to bioactive nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Re-visiting the structure of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Study on mechanism for amorphous drug stabilization using gelucire 50/13.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

In-vitro investigation regarding the effects of Gelucire® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Are iron oxide nanoparticles safe? Current knowledge and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Nanotoxicity of iron oxide nanoparticle internalization in growing neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Preparation and in vitro evaluation of folate-receptor-targeted SPION-polymer micelle hybrids for MRI contrast enhancement in cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22060963

Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits

21 January 2018

1 reference

12 December 2020

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations

1 reference

12 December 2020

Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells

1 reference

12 December 2020

The effects of unfractionated heparin on survival in patients with malignancy--a systematic review

1 reference

12 December 2020

Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting

1 reference

12 December 2020

Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats

1 reference

12 December 2020

Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake

1 reference

12 December 2020

10.3390/MOLECULES22060963

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28598368%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference